MESO Annual Cash & Cash Equivalents
$62.56 M
-$8.36 M-11.78%
30 June 2024
Summary:
As of January 23, 2025, MESO annual cash & cash equivalents is $62.56 million, with the most recent change of -$8.36 million (-11.78%) on June 30, 2024. During the last 3 years, it has fallen by -$73.87 million (-54.14%). MESO annual cash & cash equivalents is now -76.23% below its all-time high of $263.23 million, reached on June 30, 2011.MESO Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MESO Quarterly Cash And Cash Equivalents
$62.56 M
-$14.58 M-18.90%
30 June 2024
Summary:
As of January 23, 2025, MESO quarterly cash and cash equivalents is $62.56 million, with the most recent change of -$14.58 million (-18.90%) on June 30, 2024. Over the past year, it has dropped by -$14.58 million (-18.90%). MESO quarterly cash and cash equivalents is now -64.90% below its all-time high of $178.23 million, reached on December 31, 2012.MESO Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MESO Cash And Cash Equivalents Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -11.8% | -18.9% |
| 3 y3 years | -54.1% | -54.1% |
| 5 y5 years | +25.1% | -51.5% |
MESO Cash And Cash Equivalents High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -54.1% | +4.2% | -33.7% | +29.3% |
| 5 y | 5-year | -54.1% | +25.1% | -60.4% | +29.3% |
| alltime | all time | -76.2% | +4407.4% | -64.9% | +4407.4% |
Mesoblast Limited Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| June 2024 | $62.56 M(-11.8%) | $62.56 M(-18.9%) |
| Dec 2023 | - | $77.14 M(+8.8%) |
| June 2023 | $70.92 M(+18.1%) | $70.92 M(+46.5%) |
| Mar 2023 | - | $48.40 M(-28.0%) |
| Dec 2022 | - | $67.22 M(-21.0%) |
| Sept 2022 | - | $85.11 M(+41.8%) |
| June 2022 | $60.03 M(-56.0%) | $60.03 M(-21.3%) |
| Mar 2022 | - | $76.31 M(-19.2%) |
| Dec 2021 | - | $94.41 M(-18.6%) |
| Sept 2021 | - | $115.96 M(-15.0%) |
| June 2021 | $136.43 M(+5.8%) | $136.43 M(-13.5%) |
| Mar 2021 | - | $157.81 M(+104.8%) |
| Dec 2020 | - | $77.07 M(-28.7%) |
| Sept 2020 | - | $108.12 M(-16.1%) |
| June 2020 | $128.92 M(+157.8%) | $128.92 M(+115.9%) |
| Mar 2020 | - | $59.71 M(-26.2%) |
| Dec 2019 | - | $80.93 M(+137.1%) |
| Sept 2019 | - | $34.13 M(-31.7%) |
| June 2019 | $50.01 M(+34.3%) | $50.01 M(-28.5%) |
| Mar 2019 | - | $69.96 M(-8.7%) |
| Dec 2018 | - | $76.60 M(+40.3%) |
| Sept 2018 | - | $54.61 M(+46.7%) |
| June 2018 | $37.22 M | $37.22 M(-36.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2018 | - | $58.98 M(+87.6%) |
| Dec 2017 | - | $31.44 M(-32.4%) |
| Sept 2017 | - | $46.52 M(+502.4%) |
| June 2017 | $7.72 M(-64.7%) | $7.72 M(-84.4%) |
| Mar 2017 | - | $49.64 M(+189.9%) |
| Dec 2016 | - | $17.12 M(+6.8%) |
| Sept 2016 | - | $16.04 M(-26.6%) |
| June 2016 | $21.86 M(+3.5%) | $21.86 M(+103.1%) |
| Mar 2016 | - | $10.76 M(+27.6%) |
| Dec 2015 | - | $8.43 M(-60.1%) |
| June 2015 | $21.13 M(+452.0%) | $21.13 M(+84.8%) |
| Dec 2014 | - | $11.43 M(+198.7%) |
| June 2014 | $3.83 M(-51.4%) | $3.83 M(-67.7%) |
| Dec 2013 | - | $11.85 M(+50.5%) |
| June 2013 | $7.88 M(+467.4%) | $7.88 M(-95.6%) |
| Dec 2012 | - | $178.23 M(>+9900.0%) |
| June 2012 | $1.39 M(-99.5%) | $1.39 M |
| June 2011 | $263.23 M(+721.3%) | - |
| June 2010 | $32.05 M(+93.9%) | - |
| June 2009 | $16.53 M(+17.3%) | - |
| June 2008 | $14.09 M(+16.9%) | - |
| June 2007 | $12.05 M(+53.5%) | - |
| June 2006 | $7.85 M(-48.0%) | - |
| June 2005 | $15.09 M | - |
FAQ
- What is Mesoblast Limited annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Mesoblast Limited?
- What is Mesoblast Limited annual cash & cash equivalents year-on-year change?
- What is Mesoblast Limited quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Mesoblast Limited?
- What is Mesoblast Limited quarterly cash and cash equivalents year-on-year change?
What is Mesoblast Limited annual cash & cash equivalents?
The current annual cash & cash equivalents of MESO is $62.56 M
What is the all time high annual cash & cash equivalents for Mesoblast Limited?
Mesoblast Limited all-time high annual cash & cash equivalents is $263.23 M
What is Mesoblast Limited annual cash & cash equivalents year-on-year change?
Over the past year, MESO annual cash & cash equivalents has changed by -$8.36 M (-11.78%)
What is Mesoblast Limited quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of MESO is $62.56 M
What is the all time high quarterly cash and cash equivalents for Mesoblast Limited?
Mesoblast Limited all-time high quarterly cash and cash equivalents is $178.23 M
What is Mesoblast Limited quarterly cash and cash equivalents year-on-year change?
Over the past year, MESO quarterly cash and cash equivalents has changed by -$14.58 M (-18.90%)